Pulmonary rehabilitation is an important aspect of managing chronic pulmonary disease. It can help improve quality of life, increase exercise capacity, improve symptoms of shortness of breath and help manage anxiety and depression for persons with chronic respiratory diseases.. A vital part of a successful pulmonary rehabilitation program is the skill and knowledge of its healthcare providers. This program, developed jointly by the AARC and AACVPR, provides pulmonary rehabilitation specialists the knowledge necessary to be an effective member of the pulmonary rehabilitation team.

Criteria for successful completion includes viewing all course videos in their entirety. As this course provides the participant with a certificate, a 60-question post-course test is required to complete the course. Successful completion of the course test requires scoring 70% or higher on the post-course test. Attendees are allowed two attempts on the post-course test.

Successful completion of this course allows the participant to use “Certificate in Pulmonary Rehabilitation, AARC/AACVPR” in their signature line and on the resume/CV.

This course is approved by the AARC for 12.0 CRCE for respiratory therapists.

This course is approved by the Ohio Nurses Association for 12 CNE through 01/01/2020. (ONA #21308) The Ohio Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

Seminar Information
Seminar Date:
January 01, 2018
Expiration Date:
October 01, 2018 12:00 AM
Seminar Objectives
  • Pulmonary Rehabilitation: The participant will be able to define pulmonary rehabilitation, describe the essential components of a comprehensive pulmonary rehabilitation program, and explain the benefits of pulmonary rehabilitation.
  • Pathophysiology and Assessment of COPD: Explain the pathophysiology of COPD, describe the methods of COPD diagnosis, identify treatment strategies for COPD, and describe components of assessment for a patient with COPD.
  • Assessment and Management of Patients other than COPD: Discuss the pathology of non-COPD obstructive lung diseases, restrictive lung diseases and vascular lung disease, identify the educational components for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients, and discuss exercise prescription for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients.
  • Pharmacologic Interventions: List currently available pulmonary medications, describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes, and determine appropriate delivery methods for inhaled medications based on patient cognition, physical ability, and preference.
  • Supplemental Oxygen Administration: Describe the physiological benefit of supplemental oxygen, differentiate between various home oxygen delivery systems, and determine appropriate delivery system to meet patient need.
  • Exercise Assessment, Prescription, and Training in Pulmonary Rehabilitation, Part 1: Describe the purpose and relative importance of exercise testing in pulmonary rehabilitation candidates and participants, identify appropriate exercise assessments that provide meaningful information and are recognized as acceptable options and outcomes for pulmonary rehabilitation participants, demonstrate knowledge necessary pertaining to your area of clinical specialization in administering tests in accordance with safety and updated guidelines and/or cite resources where specific information pertaining to this area can be found, understand the utility of the 6 Minute Walk Test (6MWT) as it relates to pulmonary rehabilitation participants, and, in part 2, understand the information revealed from different types of exercise tests and how it can help guide individualized exercise training prescription.
  • Exercise Assessment, Prescription, and Training in Pulmonary Rehabilitation, Part 2: List the recommended core components for prescribing exercise, utilize information obtained from an exercise test to guide individualized exercise prescription, understand guidelines for prescribing exercise for endurance and resistance training for participants in pulmonary rehabilitation with chronic respiratory disease and considerations for flexibility/joint range of motion, describe strategies that are recommended for maximizing exercise training benefits in pulmonary rehabilitation patients, understand and implement disease specific considerations into pulmonary rehabilitation exercise training programs, and describe the AACVPR program certification documentation requirements for an individualized treatment plan related to exercise prescription.
  • Tobacco Cessation: Explain the scientific factors supporting tobacco cessation, identify general approaches to smoking cessation, and explain the pharmacologic agents employed in a tobacco cessation program
  • Nutrition and Pulmonary Disease: Describe the measurement of malnutrition, describe the effects of malnutrition on patients with pulmonary disease, and develop a nutrition strategy for patients with pulmonary disease.
  • Psychosocial Assessment and Intervention in Pulmonary Rehabilitation: Identify components of psychosocial assessment including psychosocial screeners, discuss common signs and symptoms of depression and anxiety including some tools that can be applicable in the pulmonary rehabilitation program, and discuss basic tenets of Motivational Interviewing to enhance adherence in pulmonary rehabilitation.
  • Collaborative Self-Management: Describe collaborative self-management, discuss the utility of using motivational interviewing as a health coaching strategy to guide positive behavior change and successful self-management, discuss the importance of self-efficacy in the success of collaborative self-management, and discuss implementation of individualized collaborative self-management training in the clinical setting.
  • Outcomes Measurement in Pulmonary Rehabilitation: Describe the foundational concepts of outcomes in healthcare, identify the evidence-based outcomes for pulmonary rehabilitation, identify valid and reliable instruments to measure pulmonary rehabilitation outcomes and discuss the process considerations when measuring outcomes in pulmonary rehabilitation.
Welcome to the course

This video introduces the learner to the AARC and AACVPR Pulmonary Rehabiltiation Certification course.

This video is approximately 2 minutes in length.

Pulmonary Rehabilitation

This presentation will define pulmonary rehabilitation and describe the essential components of a comprehensive pulmonary rehabilitation program.

At the end of this presentation, the participant will be able to

  1. Define pulmonary rehabilitation
  2. Describe the essential components of a comprehensive pulmonary rehabilitation program
  3. Explain the benefits of pulmonary rehabilitation

Ms. Limberg has no relationships to disclose.

This video is approximately 1 hour and 13 minutes in length.

Speaker Information
Trina Limberg BS, RRT, FAARC, MAACVPR  [ view bio ]
Pathophysiology and Assessment of COPD

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of COPD.

At the end of this presentation, the participant will be able to:

  1. Explain the pathophysiology of COPD
  2. Describe the methods of COPD diagnosis
  3. Identify treatment strategies for COPD
  4. Describe components of assessment for a patient with COPD

The LOTT study referenced by Dr. Casaburi in the lecture can be found at the New England Journal of Medicine website.

Dr. Casaburi discloses relationships with Boehringer Ingelheim, Novartis, GlaxoSmithKline, and Astra Zeneca.

This video is approximately 49 minutes in length.

Speaker Information
Richard Casaburi MD, MEng, PhD  [ view bio ]
Assessment and Management of Patients other than COPD

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of non-COPD chronic pulmonary disease.

At the end of this presentation, the participant will be able to

  1. Discuss the pathology of non-COPD obstructive lung diseases, restrictive lung diseases and vascular lung disease
  2. Identify the educational components for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients
  3. Discuss exercise prescription for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients

Dr. Carlin discloses that he is on the speaker bureaus for Sunovion and Monaghan and is a consultant for Sunovion, GlaxoSmithKline, Nonin, and Philips Respironics. Ms. Knipper has no relationships to disclose.

This video is approximately 58 minutes in length.

Speaker Information
Brian Carlin MD
Janie Knipper RN, MA, AE-C, FAACVPR  [ view bio ]
Pharmacologic Interventions

This presentation will identify the key components to a comprehensive disease management program and discuss the necessary skills of an effective disease manager.

At the end of this presentation, the participant will be able to:

  1. List currently available pulmonary medications
  2. Describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes
  3. Determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference

Mr. Myers has no relationships to disclose.

This video is approximately 54 minutes in length.

Speaker Information
Timothy Myers MBA, RRT-NPS, FAARC  [ view bio ]
Supplemental Oxygen Administration

This presentation will describe the physiologic benefit of supplemental oxygen while also assisting the health care professional in differentiating between home systems and determining the appropriate delivery system to meet patient need.

At the end of this presentation, the participant will be able to:

  1. Describe the physiological benefit of supplemental oxygen
  2. Differentiate between various home oxygen delivery systems
  3. Determine appropriate delivery system to meet patient need

Mr. Merriman has no relationships to disclose.

This video is approximately 37 minutes in length.

Speaker Information
Curt Merriman BA, RRT, CPFT  [ view bio ]
Exercise Assessment, Prescription, and Training in Pulmonary Rehabilitation, Part 1

This presentation is the first part of a comprehensive exercise assessment, prescription, and training in pulmonary rehabilitation module.

At the end of this presentation, the participant will be able to

  1. Describe the purpose and relative importance of exercise testing in pulmonary rehabilitation candidates and participants
  2. Identify appropriate exercise assessments that provide meaningful information and are recognized as acceptable options and outcomes for pulmonary rehabilitation participants 
  3. Demonstrate knowledge necessary pertaining to your area of clinical specialization in administering tests in accordance with safety and updated guidelines and/or cite resources where specific information pertaining to this area can be found
  4. Understand the utility of the 6 Minute Walk Test (6MWT) as it relates to pulmonary rehabilitation participants
  5. In part 2, understand the information revealed from different types of exercise tests and how it can help guide individualized exercise training prescription

Dr. Eppen discloses a teaching relationship with Relias Learning. Ms. Garvey discloses that she is on the speakers bureau for Boehringer Ingelheim.

This video is approximately 42 minutes in length.

Speaker Information
Kim Eppen PT, PhD  [ view bio ]
Chris Garvey FNP, MSN, MPA, MAACVPR  [ view bio ]
Exercise Assessment, Prescription, and Training in Pulmonary Rehabilitation, Part 2

This presentation is the conclusion of the comprehensive exercise assessment, prescription, and training in pulmonary rehabilitation module.

At the end of this presentation, the participant will be able to

  1. List the recommended core components for prescribing exercise
  2. Utilize information obtained from an exercise test to guide individualized exercise prescription
  3. Understand guidelines for prescribing exercise for endurance and resistance training for participants in pulmonary rehabilitation with chronic respiratory disease and considerations for flexibility/joint range of motion
  4. Describe strategies that are recommended for maximizing exercise training benefits in pulmonary rehabilitation patients
  5. Understand and implement disease specific considerations into pulmonary rehabilitation exercise training programs
  6. Describe the AACVPR program certification documentation requirements for an individualized treatment plan related to exercise prescription. 

Dr. Eppen discloses a teaching relationship with Relias Learning. Ms. Garvey discloses that she is on the speakers bureau for Boehringer Ingelheim.

This video is approximately 1 hour and 39 minutes in length.

Speaker Information
Kim Eppen PT, PhD  [ view bio ]
Chris Garvey FNP, MSN, MPA, MAACVPR  [ view bio ]
Tobacco Cessation

This presentation will explain the scientific factors supporting tobacco cessation, general approaches to smoking cessation, and pharmacologic agents in tobacco cessation programs.

At the end of this presentation, the participant will be able to:

  1. Explain the scientific factors supporting tobacco cessation
  2. Identify general approaches to smoking cessation
  3. Explain the pharmacologic agents employed in a tobacco cessation program.

The presenter has no relationships to disclose.

This video is approximately 23 minutes in length.

Speaker Information
Sarah Varekojis PhD, RRT, FAARC  [ view bio ]
Nutrition and Pulmonary Disease

This presentation will discuss malnutrition in the context of pulmonary disease and developing nutrition strategies for patients with pulmonary disease.

At the end of this presentation, the participant will be able to:

  1. Describe the measurement of malnutrition
  2. Describe the effects of malnutrition on patients with pulmonary disease
  3. Develop a nutrition strategy for patients with pulmonary disease

The presenter has no relationships to disclose.

This video is approximately 24 minutes in length.

Speaker Information
Karen Gregory DNP, RRT, AE-C, FAARC  [ view bio ]
Psychosocial Assessment and Intervention in Pulmonary Rehabilitation

This presentation will focus on the need for psychosocial assessment and relevant interventions for patients who are enrolled in pulmonary rehabilitation programs.  

At the end of this presentation, the participant will be able to

  1. Identify components of psychosocial assessment including psychosocial screeners
  2. Discuss common signs and symptoms of depression and anxiety including some tools that can be applicable in the pulmonary rehabilitation program
  3. Discuss basic tenets of Motivational Interviewing to enhance adherence in pulmonary rehabilitation

Dr. Eichenauer discloses that he is a co-author of the psychosocial screener, the Psychosocial Risk Factor Survey. Dr. Buckley has no relationships to disclose.

This video is approximately 1 hour and 3 minutes in length.

Speaker Information
Maria Buckley PhD, FAACVPR  [ view bio ]
Kent Eichenauer PsyD, FAACVPR  [ view bio ]
Collaborative Self-Management

This presentation will focus on collaborating with patients enrolled in pulmonary rehabilitation to maximize success of the program.

At the end of this presentation, the participant will be able to

  1. Describe collaborative self-management
  2. Discuss the utility of using motivational interviewing as a health coaching strategy to guide positive behavior change and successful self-management 
  3. Discuss the importance of self-efficacy in the success of collaborative self-management
  4. Discuss implementation of individualized collaborative self-management training in the clinical setting

Ms. Knipper discloses a teaching relationship with Relias Learning. Dr. Teneback has no relationships to disclose.

This video is approximately 60 minutes in length.

Speaker Information
Janie Knipper RN, MA, AE-C  [ view bio ]
Charlotte Teneback MD  [ view bio ]
Outcomes Measurement in Pulmonary Rehabilitation

This presentation will focus on outcome measures to identify the success of pulmonary rehabilitation programs.

At the end of this presentation, the participant will be able to

  1. Describe the foundational concepts of outcomes in healthcare
  2. Identify the evidence-based outcomes for pulmonary rehabilitation
  3. Identify valid and reliable instruments to measure pulmonary rehabilitation outcomes
  4. Discuss the process considerations when measuring outcomes in pulmonary rehabilitation

Neither Dr. Bauldoff nor Dr. Collins have relationships to disclose.

This video is approximately 38 minutes in length.

Speaker Information
Gerene Bauldoff PhD RN, FAACVPR  [ view bio ]
Eileen Collins PhD, RN, FAACVPR  [ view bio ]
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 12.00
Products
This seminar is no longer available for purchase.